YBGJ
Yubo International Biotech Ltd
Key Financials
Revenue
$12353
↑ 256.0%
Gross Profit
$8165
↑ 208.3%
Operating Income
$-1187696
↑ 32.9%
Net Income
$-1079248
↑ 45.5%
Total Liabilities
$2.8M
↓ 42.2%
Shareholders' Equity
$-1954657.00
↑ 42.9%
Total Assets
$847094.00
↓ 44.8%
Cash & Equivalents
$8062.00
↑ 14.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| ARS | 6/12/2026 | View on SEC |
| DEF 14C | 6/12/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
| 10-K | 3/31/2026 | View on SEC |
| 8-K | 1/16/2026 | View on SEC |
| 10-Q | 11/14/2025 | View on SEC |
| 10-Q | 8/13/2025 | View on SEC |
| 4 | 7/25/2025 | View on SEC |
| 4 | 7/25/2025 | View on SEC |
| SCHEDULE 13D/A | 7/25/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | YBGJ |
| Company Name | Yubo International Biotech Ltd |
| CIK | 895464 |
| Sector | Electromedical & Electrotherapeutic Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 3845 |
| SIC Description | Electromedical & Electrotherapeutic Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NY |
| Phone | 86 (010) 6615-5141 |